Intraobserver and Interobserver Agreement in the Scoring of PD-L1 (SP142) and Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancers

Objectives. Known for their poor outcomes, triple negative breast cancers (TNBCs) have been investigated for immune checkpoint inhibitors that target Programmed death ligand 1 (PD-L1). In the recent decade, tumor-infiltrating lymphocytes (TILs) have also become potential biomarkers. The aim of the...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	David Jerome Ong, Pier Angeli Medina, Sarah Jane Datay-Lim, Elizabeth Ann Alcazaren
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Philippine Society of Pathologists, Inc. 2021-12-01
Saila:	Philippine Journal of Pathology
Gaiak:	breast cancer triple negative breast cancer immunohistochemistry PD-L1 TILs
Sarrera elektronikoa:	https://philippinejournalofpathology.org/index.php/PJP/article/view/261
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!